Interleukin-2 restores natural killer activity inhibited by sera from HIV+ hemophilic patients.
Natural killer (NK) activity is impaired in patients with positive serology for the human immunodeficiency virus (HIV). We previously found an inhibitory effect of sera from hemophilic (He) HIV+ patients on normal NK activity. In the present study, we have further characterized this effect by studying its reversibility, temperature and time incubation dependence. Since interleukin 2 (IL-2) is able to enhance NK levels, we analyzed the capacity of this lymphokine to reverse the effect of He HIV+ sera. We found that when IL-2 activation of NK activity occurred simultaneously or after HIV+ serum-treatment, a significant restoration of NK function was observed. In contrast, preincubation with IL-2 did not affect the inhibitory effect exerted by HIV+ sera.
División de Immunología, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina.
M
M
Vulcano
N
N
Galassi
M
M
Felippo
D
D
Vernava
S
S
Olabuenaga
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000150:complications; D003602:Cytotoxicity, Immunologic; D015658:HIV Infections / Q000097:blood* / Q000150:complications; D006467:Hemophilia A / Q000097:blood* / Q000150:complications; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology; D013997:Time Factors
D007376:Interleukin-2